Yi-Gan San for Treatment of Charles Bonnet Syndrome (Visual Hallucination Due to Vision Loss)

2011 ◽  
Vol 34 (1) ◽  
pp. 24-27 ◽  
Author(s):  
Tsuyoshi Miyaoka ◽  
Motohide Furuya ◽  
Liaury Kristian ◽  
Rei Wake ◽  
Kazunori Kawakami ◽  
...  
Author(s):  
Tsuyshi Miyaoka ◽  
Michiharu Nagahama ◽  
Keiko Tsuchie ◽  
Maiko Hayashida ◽  
Akira Nishida ◽  
...  

1997 ◽  
Vol 31 (5) ◽  
pp. 769-771 ◽  
Author(s):  
Samson Yat-Yuk Fong ◽  
Yun-Kwok Wing

Objective: To describe a middle-aged patient with Charles Bonnet syndrome (CBS) suffering from concurrent major depression. Clinical picture: A 41-year-old Chinese man with retinitis pigmentosa developed complex and vivid visual hallucinations. This was followed by the onset of major depressive illness. His visual hallucinations were greatly influenced by his cultural background and changed during the course of his depression. Treatment: The patient was treated with imipramine. Outcome: The patient had a relapse of depression due to his non-compliance. He recovered after the resumption of imipramine but the visual hallucinations persisted. Conclusions: Patients suffering from CBS can have another concurrent psychiatric illness. The content and form of this patient's visual hallucinations were modified by his cultural background and depressive illness. Sensory deprivation is suggested to be the pathogenic mechanism of his visual hallucination.


2004 ◽  
Vol 101 (5) ◽  
pp. 846-853 ◽  
Author(s):  
Thomas M. Freiman ◽  
Rainer Surges ◽  
Vassilios I. Vougioukas ◽  
Ulrich Hubbe ◽  
Jochen Talazko ◽  
...  

✓ The development of visual hallucinations after loss of vision is known as the Charles Bonnet syndrome. This phenomenon was first described in 1760 by Charles Bonnet and others during their observations of elderly patients with degeneration of the retina or cornea. To date a clear association between visual hallucinations and neurosurgical procedures has not been reported. Because of their clear demarcation, however, surgical lesions in the cerebrum offer a unique opportunity to determine the pathoanatomical aspects of visual hallucinations. During a 3-year period, 41 consecutive patients who acquired visual field defects after neurosurgery were examined for the occurrence of visual hallucination. Postoperatively, four of these patients experienced visual hallucinations. In two of them an upper quadrantanopia developed after the patients had undergone selective amygdalohippocampectomy. In the other two patients a complete hemianopia developed, in one case after resection of a parietal astrocytoma and in the other after resection of an occipital glioblastoma multiforme. The visual hallucinations were transient and gradually disappeared between 4 days and 6 months postoperatively. The patients were aware of the fact that their hallucinations were fictitious and displayed no psychosis. Electroencephalographic recordings were obtained in only two patients and epileptic discharges were found. Deafferentiation of cortical association areas may lead to the spontaneous generation of complex visual phenomena. In the present series this phenomenon occurred in approximately 10% of patients with postoperative visual field defects. In all four cases the central optic radiation was damaged between the lateral geniculate nucleus and the primary visual cortex. The complex nature of the visual hallucination indicates that they were generated in visual association areas.


2011 ◽  
Vol 26 (S2) ◽  
pp. 378-379 ◽  
Author(s):  
H.C. Hsu ◽  
T.C. Chen ◽  
Y.S. Huang ◽  
W.X. Fan

BackgroundCBS becomes more prevalent as the population ages and the number of patients with low vision increases. Clinical features of CBS have been described as complex visual hallucinations with insight due to the vision loss or visual ability decrease in patients who’re otherwise mentally normal. We describe three typical CBS patients whose visual hallucinations developed after bilateral severe visual impairment due to diabetic retinopathy. They responded well to treatment with trazodone. The effectiveness of trazodone in these patients adds to evidence implicating serotonergic pathways in the pathogenesis of visual hallucinations.Case reportThe characteristics of 3 patients and their reactions are listed in table 1.DiscussionThis is the first report describing the effectiveness of trazodone in treating typical CBS patients. It indicates that trazodone is an safer option for the treatment of CBS, especially in the elderly, diabetic population. In addition to having fewer interactions with comedications, trazodone has fewer adverse effects and relative lower body weight gain risk compared to anticonvulsants and neuroleptics. CBS is a condition that many clinicians aren’t very familiar with, yet it’s a surprisingly high prevalence rate (10%-30%) among the visually impaired. Clinicians must therefore keep in mind and ask elderly people with visual impairment whether they’ve hallucinations.


Sign in / Sign up

Export Citation Format

Share Document